Business · 17/11/20261 min read
Opinion/decision on a Paediatric investigation plan (PIP): Galafold, migalastat hydrochloride, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Congenital, familial and genetic disorders, PIP number: P/0172/2023
Summary
Opinion/decision on a Paediatric investigation plan (PIP): Galafold, migalastat hydrochloride, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Congenital, familial and genetic disorders, PIP number: P/0172/2023